cdx2cea
Published in Zenodo, 2021
Recommended citation: Alarid-Escudero F, Schrag D, Kuntz KM (2021). {cdx2cea}: A cost-efectiveness analysis of testing stage II colon cancer patients for the absence of CDX2 biomarker followed by adjuvant chemotherapy (Version v1.0.0). Zenodo. 10.5281/zenodo.5093594.
cdx2cea is an R package that implements the cost-effectiveness analysis (CEA) of testing average-risk Stage II colon cancer patients for the absence of CDX2 biomarker expression followed by adjuvant chemotherapy.
cdx2cea is part of the following manuscript:
- Alarid-Escudero F, Schrag D, Kuntz KM. (2021) “CDX2 biomarker testing and adjuvant therapy for stage II colon cancer: An exploratory cost-effectiveness analysis” Value in Health (Online First).
The release that accompanies the published article has been archived in zenodo.
GitHub repository and the accompanying manuscript can be downloaded here.